SEC Filing Analysis: GE HealthCare Technologies Inc. (GEHC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Executive received standard annual equity compensation (RSUs and Options) with 3-year vesting.
• Market Impact: Neutral - Routine administrative filing.

Company Information

Field	Value
Company	GE HealthCare Technologies Inc.
Ticker Symbol	GEHC
CIK	0001932393
Industry	Medical Devices

Insider Information

Field	Value
Name	Bankes Jeannette
CIK	0001920839
Title/Position	CEO, Patient Care Solutions
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-02
Transaction Code	A (Grant/Award)
Security Type	Common Stock (RSUs) & Options
Shares Involved	6,861 (Stock) + 18,038 (Options)
Price Per Share	$0.00
Total Value	$0 (Compensation)
Shares Owned After	43,892
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Grant)
% of Market Cap	0.00%
Shares Transacted	24,899 (Combined)
% of Shares Outstanding	~0.005%
Post-Transaction Ownership	43,892 shares (<0.01% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market cap of $38.41B, this compensation grant is financially immaterial to the company's bottom line.
• Ownership Concentration: The insider holds a minor stake relative to the 455M+ shares outstanding.
• Dilution Impact: The grant represents approximately 0.005% of shares outstanding, resulting in negligible dilution for existing shareholders.
• Transaction Significance: This is a "Code A" transaction, indicating a grant from the company to the employee, rather than an open market purchase or sale.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a standard part of executive compensation packages and do not signal insider sentiment regarding the stock's future price performance in the same way open market purchases do.

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Vesting Schedule: Both the RSUs and Options vest over a three-year period (33% in 2027, 33% in 2028, 34% in 2029), aligning executive interest with long-term shareholder value.
• Option Strike Price: The options have an exercise price of $80.16, setting a performance baseline for the executive.